Direct Answer
Managed care organizations (MCOs) and health insurance companies pay for healthcare services on behalf of their enrollees, collecting premiums from employers, individuals, and government programs in exchange for covering medical costs. Major MCOs include UnitedHealth Group (the largest U.S. health insurer), CVS Health/Aetna, Elevance Health (formerly Anthem), Centene, and Humana. Investors analyze managed care on the medical loss ratio (MLR), enrollment growth, premium rate changes, Medicare Advantage Stars ratings, and the relationship between premium increases and medical cost trends. Managed care is regulated at both the federal and state level, with the Affordable Care Act (ACA), Medicare, and Medicaid programs setting the economic framework for most of the business.
Industry Structure and Enrollment Segments
Commercial insurance: Employer-sponsored health insurance is the largest segment of U.S. health coverage. MCOs sell group health plans to employers who provide insurance as a benefit to employees. Large employers often self-insure (bearing the actual medical cost themselves) and hire MCOs as administrative service organizations (ASO) to process claims and manage networks -- the MCO earns a per-member-per-month administrative fee rather than retaining premium risk. Small and mid-size employers more commonly purchase fully-insured coverage where the MCO retains risk. The commercial market is competitive and relatively mature in the U.S.
Medicare Advantage: Medicare Advantage (MA) is the privatized version of Medicare, in which the Centers for Medicare and Medicaid Services (CMS) pays MCOs a risk-adjusted premium per enrollee to provide Medicare-equivalent coverage plus supplemental benefits (dental, vision, fitness). MA has grown from roughly 20% of Medicare beneficiaries in 2010 to approximately 55% by 2024, as beneficiaries have preferred MA plans' supplemental benefits and often lower out-of-pocket costs versus traditional fee-for-service Medicare. MA is the highest-growth and historically highest-margin segment for managed care. However, CMS adjusts MA payment rates annually, and 2024-2025 rate adjustments that were below medical cost trend -- combined with higher-than-expected utilization from patients whose care was deferred during COVID -- created significant MA profitability pressures for Humana and others.
Medicaid managed care: States contract with MCOs (Centene, Molina Healthcare, CVS Health) to manage Medicaid benefits for low-income enrollees. MCOs receive a capitated (per-member-per-month) payment from the state and are responsible for all covered medical costs. Medicaid redetermination cycles (annual review of eligibility) can dramatically affect enrollment; the post-COVID Medicaid "unwinding" (resumption of eligibility redeterminations after the COVID public health emergency) removed approximately 20 million enrollees from Medicaid in 2023-2024, creating enrollment headwinds for Medicaid-focused MCOs.
Pharmacy benefit management and vertical integration: UnitedHealth Group (Optum), CVS Health (Caremark), and Cigna (Express Scripts) have vertically integrated pharmacy benefit management (PBM) -- negotiating drug prices with manufacturers and processing pharmacy claims -- with health insurance. This vertical integration allows MCOs to capture PBM economics and use data across insurance and pharmacy to improve care management. Critics argue that PBM vertical integration creates conflicts of interest and reduces drug cost transparency; legislative and regulatory scrutiny (including the FTC's PBM investigation under the FTC Act) has increased.
Medical Loss Ratio, Stars Ratings, and CMS Rate-Setting
Medical Loss Ratio (MLR): The MLR is the percentage of premium revenue spent on medical claims (healthcare services) and quality improvement activities. Under the ACA's Section 2718, health insurance issuers must meet minimum MLR thresholds: 85% for large group plans, 80% for individual and small group plans. If an insurer's MLR is below the threshold, it must rebate the difference to policyholders. For investors, MLR is the inverse of the administrative cost ratio: an MLR of 87% means 13% of premium is available for selling, general and administrative costs and profit. When medical costs rise faster than premiums (MLR expansion), profitability compresses. MCOs manage MLR through utilization management (prior authorization requirements, care coordination programs), network design (narrowing networks to lower-cost providers), risk adjustment (enrolling a sicker population generates higher CMS payments that should offset higher claims), and repricing (raising premiums at renewal to reflect experience).
Medicare Advantage Stars Ratings: CMS rates each Medicare Advantage plan on a 1-5 star scale based on quality and performance metrics including preventive care rates, disease management, customer satisfaction, and appeals processing. A plan with 4 or more Stars receives a quality bonus payment from CMS (approximately 5% additional premium per member) and avoids certain regulatory restrictions on marketing and enrollment. The Stars system creates a direct financial incentive for MCOs to invest in care quality and member satisfaction. Plans that fall below 4 Stars lose the bonus payment, which can be worth hundreds of millions of dollars annually for large MA plans. Stars ratings are determined annually and create meaningful earnings variability; Humana's 2024 Stars downgrades contributed significantly to its profitability challenges.
CMS rate-setting: CMS publishes annual Medicare Advantage payment rates (the "advance notice" in February and final rates in April) that set the per-member premium MCOs receive for MA enrollees. These rates are benchmarked to traditional Medicare costs by county, adjusted for demographics and health status (risk adjustment). When CMS raises rates below the MCO's medical cost trend, MCOs face margin compression unless they raise supplemental benefit reductions or exit unprofitable markets. The 2024 MA rate environment was challenging: CMS raised benchmark rates approximately 3.7% for 2024 plans, but medical cost trends (post-COVID utilization catch-up) ran at 5-8%, causing significant MLR deterioration for major MA plans.
Key Metrics to Track
| Metric | What It Measures | Benchmark Context |
|---|---|---|
| Medical Loss Ratio (MLR) | Medical costs / premium revenue; profitability signal | ACA minimum: 80-85%; MCO target: 82-87%; above 90% = margin pressure; below 82% = may require rebates or premium repricing |
| Enrollment Growth | Members added net of departures by segment; top-line volume | MA enrollment: growing 5-8%/year structurally; commercial: 0-2%; Medicaid: affected by redetermination cycles and state contract wins/losses |
| Premium Revenue per Member | Average premium collected per enrolled member; pricing trend | Rising PMPM = rate increases ahead of cost trend; flat or falling = competitive pressure or plan mix shift toward lower-cost government programs |
| Stars Ratings Distribution | % of MA members in plans with 4+ Stars; bonus payment eligibility | Large MCOs target 80%+ of MA members in 4+ Star plans; Stars bonus = ~5% additional CMS premium; downgrade = immediate margin hit |
| Operating Margin by Segment | Profitability of each business line (commercial, MA, Medicaid, Optum) | MA at peak: 6-8% operating margin; commercial: 5-7%; Medicaid: 2-4%; UnitedHealth Optum: 8-10% |
| Prior Authorization Approval Rate | % of requested services approved; utilization management effectiveness | Regulatory and legislative pressure increasing; CMS 2024 rule limits prior auth response times; high denial rates = regulatory scrutiny risk |
| Days in Claims Payable | Estimate of unpaid medical claims (IBNR: incurred but not reported); reserving adequacy | Higher DCP = more conservative reserving (good); unexpected DCP decline = potentially under-reserved claims catching up |
Principal Risks
- Medicare Advantage utilization and rate mismatch: Post-COVID utilization normalization combined with CMS rate increases below medical cost trend created the largest MA profitability crisis in years for 2024-2025. Humana issued multiple earnings warnings; Centene and CVS Health also experienced MLR deterioration. When medical utilization rises faster than anticipated (patients using more healthcare services than historical patterns predicted), MLRs rise and margins compress quickly because premiums are set annually in advance.
- ACA exchange market volatility: The individual market (ACA exchanges) is subject to regulatory changes that affect plan design, premium subsidies, and competitive dynamics. The enhanced ACA subsidies enacted under the American Rescue Plan Act (ARPA) and extended by the Inflation Reduction Act significantly expanded ACA exchange enrollment, benefiting MCOs with exchange plans. These subsidies are scheduled to expire after 2025; expiration could drive 3-5 million people off exchange plans, creating enrollment and revenue headwinds for MCOs relying on this market.
- Prior authorization regulatory pressure: Prior authorization -- the process by which MCOs require advance approval before covering certain medical procedures -- has become a major political and regulatory target. CMS issued rules in 2024 limiting prior authorization response times and requiring electronic PA capabilities; legislative proposals in Congress would restrict PA for specific populations. Restrictions on prior authorization could increase MLR by reducing utilization management effectiveness.
- Cybersecurity and claims processing disruption: The February 2024 Change Healthcare cyberattack (Change Healthcare is a subsidiary of UnitedHealth Group's Optum) disrupted claims processing for thousands of healthcare providers across the U.S. for months. The attack highlighted the systemic risk of healthcare data and payment infrastructure concentration, led to $872 million in direct costs for UnitedHealth, and triggered Congressional scrutiny. Healthcare IT infrastructure concentration creates systemic risk that affects the entire managed care ecosystem.
- Political and regulatory risk: Healthcare policy is persistently subject to legislative change. Proposals to expand Medicare negotiation rights (partially implemented under the IRA), establish a public option, change Medicaid financing, or alter ACA subsidy structures all create material uncertainty for managed care business models. The Affordable Care Act itself faced years of legal and legislative challenges; the legal framework for U.S. health insurance remains subject to political risk.
Healthcare Services Analysis Guides
FAQ
What is the medical loss ratio and how does it affect managed care profitability?
The medical loss ratio (MLR) is the percentage of premium revenue that an insurance company spends on medical claims and quality improvement activities. If UnitedHealth collects $100 in premiums and pays out $84 in medical claims and $2 in quality programs, its MLR is 86%. The remaining 14% must cover selling and administrative expenses and generate profit. The ACA established minimum MLR floors: 85% for large group insurance, 80% for individual and small group markets. If an insurer's MLR falls below these thresholds, it must rebate the difference to policyholders. For investors, MLR is the key profitability signal. When medical costs rise faster than expected (utilization catches up post-COVID, new expensive drugs or treatments become standard of care, an aging Medicare Advantage population uses more services), MLR rises and profit margins compress. Because premiums are set annually in advance based on projected medical cost trends, a trend miss -- actual costs running above projections -- cannot be immediately corrected; the insurer must absorb elevated MLR until the next premium repricing cycle. MCOs manage MLR through utilization management (prior authorization, care coordination, disease management programs), network contracting (negotiating lower rates with hospitals and physicians), and risk adjustment accuracy (ensuring CMS pays appropriately for the health status of enrolled members). Small changes in MLR have large profitability impacts: a 100 basis point MLR increase on $100 billion of MA premium revenue represents $1 billion of pretax earnings impact.
How does Medicare Advantage work and why has it been growing so rapidly?
Medicare Advantage (MA) is the privatized alternative to traditional fee-for-service (FFS) Medicare, created by the Balanced Budget Act of 1997 and expanded by the Medicare Modernization Act of 2003. Instead of the federal government directly paying healthcare providers for Medicare beneficiaries' services (FFS), CMS pays private insurance companies (MCOs) a risk-adjusted capitated premium per member per month to provide all Medicare-covered services plus supplemental benefits. MA plans must cover everything traditional Medicare covers (Parts A and B: hospital and physician services), and most include Part D prescription drug coverage and supplemental benefits (dental, vision, hearing, fitness, over-the-counter allowances) that traditional Medicare does not cover. These supplemental benefits are the primary driver of MA's rapid growth: beneficiaries choosing between "free" traditional Medicare (which has no premium for Part A but has significant cost sharing and no supplemental benefits) and an MA plan with zero additional premium AND dental/vision/fitness coverage have a strong financial incentive to choose MA. MA enrollment has grown from about 12 million in 2010 to approximately 33 million in 2024, representing about 55% of Medicare beneficiaries. MCOs profit when they manage medical costs below the CMS capitated payment; they lose money when actual costs (particularly from sicker-than-expected enrollees or rising utilization) exceed the capitated payment. The CMS risk adjustment system, which adjusts payments based on the diagnosed health status of each enrollee, is the mechanism for aligning payments with expected costs -- but risk adjustment models are periodically updated and audited (the Risk Adjustment Data Validation, or RADV, audit program), creating regulatory and financial risk for MCOs with aggressive risk coding practices.
What are Medicare Advantage Stars ratings and why do they matter financially?
CMS rates each Medicare Advantage plan on a 1-5 star quality scale based on dozens of performance measures across five domains: staying healthy (preventive screenings, immunizations), managing chronic conditions (diabetes care, blood pressure control), member experience (CAHPS survey scores), member complaints and appeals, and health plan administrative performance. Ratings are published annually and reflect the prior year's performance. Plans earning 4 or more Stars receive a quality bonus payment from CMS: approximately 5% additional per-member-per-month capitated payment for 4-Star plans and a somewhat higher bonus for 4.5 and 5-Star plans. For a large MA plan with 3 million members, a 5% Stars bonus on an average monthly payment of $1,000 per member equals approximately $1.8 billion in additional annual revenue. This financial magnitude makes Stars ratings a major driver of MA plan profitability and has motivated MCOs to invest heavily in Stars-related activities: closing care gaps (calling members to schedule preventive screenings), member satisfaction programs, and appeals process improvements. Plans below 4 Stars not only lose the bonus but also face marketing restrictions that make it harder to attract new enrollees. Stars ratings create year-to-year earnings volatility: a plan that falls from 4 to 3.5 Stars loses its quality bonus in the following plan year, creating a significant earnings headwind. Conversely, a plan improving from 3.5 to 4 Stars gains the bonus, creating an earnings tailwind. Humana's 2024 earnings deterioration was partly driven by Stars rating downgrades on several large plans.
How do Medicaid redeterminations affect managed care company enrollment?
Medicaid provides health coverage to low-income Americans, financed jointly by federal and state governments. Normally, states must annually verify that Medicaid enrollees still meet eligibility requirements (redeterminations). During the COVID-19 public health emergency (2020-2023), Congress prohibited states from disenrolling anyone from Medicaid in exchange for enhanced federal funding, allowing Medicaid enrollment to swell from approximately 70 million to nearly 95 million beneficiaries. The Consolidated Appropriations Act of 2023 ended the continuous enrollment requirement, requiring states to begin redeterminations in April 2023. The "Medicaid unwinding" -- the process of re-verifying eligibility for all 95 million enrollees over approximately 12-14 months -- led to approximately 20 million enrollment losses by mid-2024, as many enrollees had moved above the income threshold or had not responded to enrollment verification notices. For Medicaid managed care companies (Centene, Molina Healthcare, CVS Health's Medicaid plans), this created significant enrollment and revenue headwinds as their enrollment bases shrank. The impact varied: some lost members were actually ineligible and their loss reduces claims costs proportionally; others were eligible people who failed to re-enroll due to administrative burden and will eventually re-enroll. Medicaid MCOs with high proportions of members in income ranges near the eligibility threshold faced higher redetermination-related attrition.
Why is UnitedHealth Group so much larger than its managed care peers?
UnitedHealth Group is the largest health insurer and one of the largest companies in the U.S. by revenue (approximately $370-380 billion annually) due to a unique combination of insurance scale and a separately profitable healthcare services business (Optum). While UnitedHealthcare (the insurance segment) is the largest U.S. health insurer by enrollment (~50 million members), Optum contributes approximately 50% of UnitedHealth's operating income. Optum operates three segments: OptumHealth (physician practices, surgery centers, home health -- approximately 90,000 employed physicians); OptumInsight (technology services, analytics, claims processing, Change Healthcare after its acquisition); and OptumRx (the third-largest pharmacy benefit manager with ~100 million members and specialty pharmacy operations). This vertical integration allows UnitedHealth to capture value across the healthcare value chain: a member enrolled in UnitedHealthcare generates insurance premium, receives care at an OptumHealth clinic, has prescriptions processed through OptumRx, and has claims managed through OptumInsight technology -- each step generating margin for UnitedHealth rather than flowing to independent parties. The February 2024 Change Healthcare cyberattack disrupted this integration strategy by exposing the systemic risk of concentrated healthcare payment infrastructure. UnitedHealth's competitive advantages are scale (the largest network in most markets), data (claims data across 50 million members supports utilization analytics and care management), and vertical integration that is difficult for pure-play insurers to replicate without similar acquisition programs.
References
- CMS (Centers for Medicare and Medicaid Services): Medicare Advantage rate notices and Stars methodology (cms.gov)
- KFF (Kaiser Family Foundation): Health insurance market data and Medicare Advantage enrollment trends (kff.org)
- NAIC (National Association of Insurance Commissioners): State insurance regulatory standards (naic.org)